logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
X

Xinan Wang

Harvard T.H. Chan School of Public Health
H指数:24
被引数:2,476

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Long-term overall survival with dual CTLA-4 and PD-L1 or PD-1 blockade and biomarker-based subgroup analyses in patients with advanced non-small-cell lung cancer: a systematic review and reconstructed individual patient data meta-analysis

晚期非小细胞肺癌患者接受双重CTLA-4和PD-L1或PD-1阻断治疗及生物标志物基础亚组分析的长期总生存：一项系统评价和重建个体患者数据荟萃分析

The Lancet Oncology
IF0
2025-09-290
PRE
Alessandro Di Federico; Sara Stumpo; Francesco Mantuano; Andrea De Giglio; Francesca Lo Bianco; Federica Pecci; Joao V Alessi; Xinan Wang; Francesca Sperandi; Barbara Melotti; Francesco Gelsomino; Ferdinandos Skoulidis; Marina C Garassino; Solange Peters; Mark M Awad; Andrea Ardizzoni; Biagio Ricciuti
First-line immunotherapy with or without chemotherapy versus BRAF plus MEK inhibitors in BRAFV600E-mutated metastatic non-small-cell lung cancer (FRONT-BRAF): a multicentre, retrospective cohort study

一线免疫治疗联合或不联合化疗与BRAF联合MEK抑制剂在BRAFV600E突变型转移性非小细胞肺癌中的比较（FRONT-BRAF）：一项多中心、回顾性队列研究

The Lancet Oncology
IF0
2025-09-290
PRE
Alessandro Di Federico; Kaiwen Wang; Monica F Chen; Adam A Barsouk; Arianna Pagliaro; Lanyi N Chen; Francesca R Ogliari; Paul Stockhammer; Rajat Thawani; Shahm Raslan; Eleonora Gariazzo; Francesca Fusco; Grace M Hambelton; Fabrizio Citarella; David Meyer; Mihaela Aldea; Andrea De Giglio; Joao V Alessi; Federica Pecci; Francesco Gelsomino; Marcelo Corassa; Natalie I Vokes; Xinan Wang; Dario de Biase; Fawzi Abu Rous; Phurin Areesawangkit; Omar Elghawy; Alessio Cortellini; Giulio Metro; Roberto Ferrara; Mark M Awad; Aliyah Pabani; Joseph C Murray; Federico Cappuzzo; Marina C Garassino; Ibiayi Dagogo-Jack; Gregory Riely; Michael Grant; Benjamin O Herzberg; Andrea Ardizzoni; David Planchard; Bruce E Johnson; Corey J Langer; Michael Offin; Marcelo V Negrao; Biagio Ricciuti
Re: Ruben Raychaudhuri, Ali Raza Khaki, Mary W. Redman, et al. Neoadjuvant Pembrolizumab and Accelerated Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Nonurothelial Histologic Subtypes of Muscle-invasive Bladder Cancer: A Phase 2 Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2025.07.002

Re: Ruben Raychaudhuri, Ali Raza Khaki, Mary W. Redman, 等. 新辅助培美曲塞及加速甲氨蝶呤、长春碱、多柔比星和顺铂方案在非尿路上皮性肌层浸润性膀胱癌不同组织学亚型中的应用：一项Ⅱ期临床试验。欧洲泌尿学杂志。待发表。https://doi.org/10.1016/j.eururo.2025.07.002

European Urology
IF25.2
2025-09-240
PRE
Xuenan Li; Xinan Wang; Gong Zhang
DNA methyltransferase 3A (DNMT3A) mutations and PD-(L)1 blockade efficacy in non-small cell lung cancer

DNA甲基转移酶3A（DNMT3A）突变与非小细胞肺癌中PD-(L)1阻断疗法的疗效

Annals of Oncology
IF65.4
2025-06-180
PRE
B. Ricciuti; S. Scalera; X. Wang; A. Elkrief; M. Tagliamento; E. Gariazzo; F. Paoloni; P.G. Miller; F. Pecci; A. Di Federico; V. Santo; J.V. Alessi; M. Aldea; E. Garbo; G. Lamberti; W. Zrafi; J.B. Micol; L.M. Sholl; M. Nishino; F. Cappuzzo; N. Calonaci; G. Caravagna; R. Ferrara; B. Besse; A. Schoenfeld; M. Maugeri-Sacca; M.M. Awad
Lung adenocarcinomas with mucinous histology: clinical, genomic, and immune microenvironment characterization and outcomes to immunotherapy-based treatments and KRASG12C inhibitors

黏液性组织学特征的肺腺癌：临床、基因组学和免疫微环境特征及对基于免疫疗法治疗和KRASG12C抑制剂的疗效

ANNALS OF ONCOLOGY
IF65.4
2025-03-014
PRE
Di Federico, A.; Hong, L.; Elkrief, A.; Thummalapalli, R.; Cooper, A. J.; Ricciuti, B.; Digumarthy, S.; Alessi, J. V.; Gogia, P.; Pecci, F.; Makarem, M.; Gandhi, M. M.; Garbo, E.; Saini, A.; De Giglio, A.; Favorito, V.; Scalera, S.; Cipriani, L.; Marinelli, D.; Haradon, D.; Nguyen, T.; Haradon, J.; Voligny, E.; Vaz, V.; Gelsomino, F.; Sperandi, F.; Melotti, B.; Ladanyi, M.; Zhang, J.; Gibbons, D. L.; Heymach, J. V.; Nishino, M.; Lindsay, J.; Rodig, S. J.; Pfaff, K.; Sholl, L. M.; Wang, X.; Johnson, B. E.; Janne, P. A.; Rekhtman, N.; Maugeri-Sacca, M.; Heist, R. S.; Ardizzoni, A.; Awad, M. M.; Arbour, K. C.; Schoenfeld, A. J.; Vokes, N. I.; Luo, J.
Tumor Immunophenotypic Correlates in Patients Aged 80 Years or Older With Non-Small Cell Lung Cancer and Outcomes to First-Line Pembrolizumab in PD-L1 High (≥50%) Patients

老年非小细胞肺癌患者（≥80岁）的肿瘤免疫表型相关性及PD-L1高表达（≥50%）患者接受一线帕博利珠单抗治疗的结局

Clinical Lung Cancer
IF3.3
2025-02-040
PRE
Adriana P.C. Barrichello; Arielle Elkrief; Biagio Ricciuti; Teja Ganta; Thomas U. Marron; Xinan Wang; William Lotter; James Lindsay; Valentina Santo; Alessio Cortellini; Bijaya Sharma; Kristen Felt; Kathleen Pfaff; Giuseppe Lamberti; Federica Pecci; Alessandro Di Federico; Maisam Makarem; Malini M. Gandhi; Tom Nguyen; Danielle Haradon; Victor R. Vaz; Bruce E. Johnson; Neha Debnath; Yinghong Wang; Andrew G. Kuang; Anwaar Saeed; Maluki Radford; Christine M. Lovly; Caroline A. Nebhan; David J. Pinato; Scott J. Rodig; Adam J. Schoenfeld; Mark M. Awad; Joao V. Alessi; Abdul Rafeh Naqash
Automated chest CT three-dimensional quantification of body composition: adipose tissue and paravertebral muscle
SCIENTIFIC REPORTS
IF3.9
2024-12-300
OAAI
Hata, Akinori; Muraguchi, Yohei; Nakatsugawa, Minoru; Wang, Xinan; Song, Jiyeon; Wada, Noriaki; Hino, Takuya; Aoyagi, Kota; Kawagishi, Masami; Negishi, Takuo; Valtchinov, Vladimir I.; Nishino, Mizuki; Koga, Akihiro; Sugihara, Naoki; Ozaki, Masahiro; Hunninghake, Gary M.; Tomiyama, Noriyuki; Schiebler, Mark L.; Li, Yi; Christiani, David C.; Hatabu, Hiroto
Intrapatient variation in PD-L1 expression and tumor mutational burden and the impact on outcomes to immune checkpoint inhibitor therapy in patients with non-small-cell lung cancer

非小细胞肺癌患者PD-L1表达和肿瘤突变负荷的体内变化及其对免疫检查点抑制剂治疗结局的影响

ANNALS OF ONCOLOGY
IF65.4
2024-10-010
PRE
Di Federico, A.; Alden, S. L.; Smithy, J. W.; Ricciuti, B.; Alessi, J. V.; Wang, X.; Pecci, F.; Lamberti, G.; Gandhi, M. M.; Vaz, V. R.; Spurr, L. F.; Sholl, L. M.; Pfaff, K. L.; Rodig, S. J.; Li, Y. Y.; Cherniack, A. D.; Nishino, M.; Johnson, B. E.; Awad, M. M.
Automated Interstitial Lung Abnormality Probability Prediction at CT: A Stepwise Machine Learning Approach in the Boston Lung Cancer Study
RADIOLOGY
IF15.2
2024-09-010
OA
Hata, Akinori; Aoyagi, Kota; Hino, Takuya; Kawagishi, Masami; Wada, Noriaki; Song, Jiyeon; Wang, Xinan; Valtchinov, Vladimir I.; Nishino, Mizuki; Muraguchi, Yohei; Nakatsugawa, Minoru; Koga, Akihiro; Sugihara, Naoki; Ozaki, Masahiro; Hunninghake, Gary M.; Tomiyama, Noriyuki; Li, Yi; Nakatsugawa, M.; Christiani, David C.; Hatabu, Hiroto
Three-Year Overall Survival Outcomes and Correlative Analyses in Patients With NSCLC and High (50%-89%) Versus Very High (≥90%) Programmed Death-Ligand 1 Expression Treated With First-Line Pembrolizumab or Cemiplimab
JTO CLINICAL AND RESEARCH REPORTS
IF3.5
2024-09-013
OA
Ricciuti, Biagio; Elkrief, Arielle; Lin, Jessica; Zhang, Jianjun; Alessi, Joao, V; Lamberti, Giuseppe; Gandhi, Malini; Di Federico, Alessandro; Pecci, Federica; Wang, Xinan; Makarem, Maisam; Hidalgo Filho, Cassio Murilo; Gorria, Teresa; Saini, Arushi; Pabon, Cindy; Lindsay, James; Pfaff, Kathleen L.; Welsh, Emma L.; Nishino, Mizuki; Sholl, Lynette M.; Rodig, Scott; Kilickap, Saadettin; Rietschel, Petra; Mcintyre, Debra AG.; Pouliot, Jean-Francois; Altan, Mehmet; Gainor, Justin F.; Heymach, John, V; Schoenfeld, Adam J.; Awad, Mark M.
Activating Point Mutations in the MET Kinase Domain Represent a Unique Molecular Subset of Lung Cancer and Other Malignancies Targetable with MET Inhibitors
CANCER DISCOVERY
IF33.3
2024-04-023
OAAI
Pecci, Federica; Nakazawa, Seshiru; Ricciuti, Biagio; Harada, Guilherme; Lee, Jessica K.; Alessi, Joao V.; Barrichello, Adriana; Vaz, Victor R.; Lamberti, Giuseppe; Di Federico, Alessandro; Gandhi, Malini M.; Gazgalis, Dimitris; Feng, William W.; Jiang, Jie; Baldacci, Simon; Locquet, Marie-Anais; Gottlieb, Felix H.; Chen, Monica F.; Lee, Elinton; Haradon, Danielle; Smokovich, Anna; Voligny, Emma; Nguyen, Tom; Goel, Vikas K.; Zimmerman, Zachary; Atwal, Sumandeep; Wang, Xinan; Bahcall, Magda; Heist, Rebecca S.; Iqbal, Sumaiya; Gandhi, Nishant; Elliott, Andrew; Vanderwalde, Ari M.; Ma, Patrick C.; Halmos, Balazs; Liu, Stephen V.; Che, Jianwei; Schrock, Alexa B.; Drilon, Alexander; Janne, Pasi A.; Awad, Mark M.

研究方向

暂未获取到该数据
B
Biagio Ricciuti
H 指数:54论文数:1,064被引数:1.0万
M
Mark M. Awad
H 指数:86论文数:1,447被引数:3.0万
J
Joao V. Alessi
H 指数:28论文数:796被引数:2,975
A
Alessandro Di Federico
H 指数:30论文数:753被引数:2,987
F
Federica Pecci
H 指数:20论文数:628被引数:1,422
B
Bruce E. Johnson
H 指数:123论文数:1,090被引数:8.7万
G
Giuseppe Lamberti
H 指数:36论文数:824被引数:4,792
D
David C. Christiani
H 指数:115论文数:1,752被引数:7.1万
L
Lynette M. Sholl
H 指数:97论文数:1,164被引数:3.8万
M
Malini Gandhi
H 指数:11论文数:415被引数:374